FIELD: chemistry.
SUBSTANCE: invention relates to a method of producing a compound of formula (I), comprising steps of [C] and [D], wherein [C] a compound of general formula (XI), in which R2 denotes alkyl with 1–4 carbon atoms, is reacted one after another at the first step [C-1] in the presence of a base with an acid chloride of general formula (XII), where PG denotes a protective group, and obtained intermediate product is then reacted at next step [C-2] in presence of base with phenylhydrazine compound of general formula (XIII), wherein R1A and R1B are independently selected from a group consisting of hydrogen, fluorine, chlorine, methyl, monofluoromethyl, difluoromethyl, trifluoromethyl, ethyl, methoxy, difluoromethoxy and trifluoromethoxy, to obtain 1,2,4-triazolyl compound of general formula (XIV), in which the residues PG, R1A and R1B have the values given above, and at the next step [D] by removing the protective group PG is converted to a compound of general formula (I). Invention also relates to a compound of general formula (X), to a compound of general formula (XI).
,
EFFECT: novel method of producing a compound of formula (I) with high output, suitable for synthesis on an industrial scale.
12 cl, 1 dwg, 1 tbl, 23 ex
Title | Year | Author | Number |
---|---|---|---|
BENZOXAZEPINE PI3K INHIBITORS AND METHODS OF USE | 2010 |
|
RU2600927C2 |
BICYCLIC KETONES AND METHODS OF THEIR USE | 2018 |
|
RU2797922C2 |
1-(4-ISOXAZOLE-5-YL)-1H-PYRAZOLE-1-YL)-2-METHYLPROPANE-2-OL DERIVATIVES AND RELATED COMPOUNDS AS IL-17 AND IFN-GAMMA INHIBITORS FOR TREATMENT OF AUTOIMMUNE DISEASES AND CHRONIC INFLAMMATION | 2018 |
|
RU2785342C2 |
TRIAZOLO-PYRIMIDINE COMPOUNDS AND THEIR USE | 2019 |
|
RU2802866C2 |
BENZOXAZEPINE PI3 INHIBITORS AND METHODS OF USE | 2010 |
|
RU2654068C1 |
PYRIDAZINE DERIVATIVES AS RORc MODULATORS | 2017 |
|
RU2757571C2 |
SUBSTITUTED DIHYDROPYRAZOLONES FOR TREATING CARDIOVASCULAR AND HEMATOLOGIC DISEASES, USE THEREOF, DRUG AND METHOD OF TREATING AND/OR PREVENTING | 2012 |
|
RU2611012C2 |
ISOINDOLINONE INHIBITORS OF MDM2-P53 INTERACTION WITH ANTI-CANCER ACTIVITY | 2016 |
|
RU2797295C1 |
SUBSTITUTED [1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-7-YL COMPOUNDS AS THE INHIBITORS OF PDE2 | 2015 |
|
RU2659070C9 |
INHIBITORS OF AKT ACTIVITY | 2010 |
|
RU2579513C2 |
Authors
Dates
2021-02-11—Published
2017-05-02—Filed